Showing results (361-370 of 492) with videos related to
Sort By:
Pageof 50
Acta Neurologica Scandinavica|July 13, 2005
From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, ItalyG Tognoni, R Ceravolo, B Nucciarone, et al.The New England Journal of Medicine|July 2, 1992
The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study GroupA P Maggioni, M G Franzosi, E Santoro, et al.Neurobiology of Aging|February 15, 2005
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patientsL Migliore, I Fontana, F Trippi, et al.Italian Journal of Neurological Sciences|February 1, 1997
Access to rehabilitation facilities in an unselected hospital population affected by acute strokeR Cavestri, L Buontempi, M Arreghini, et al.The Journal of Laboratory and Clinical Medicine|June 1, 1984
Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet functionC Cerletti, M Bonati, A del Maschio, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 23, 2025
Functional propriospinal myoclonus in Alzheimer's disease: coincidence or a new challenge?Enrico Bergamin, F Turco, E Unti, et al.Toxicology Letters|December 1, 1985
Caffeine distribution in acute toxic response among inbred miceM Bonati, L Jiritano, A Bortolotti, et al.Cancer Treatment Reports|May 1, 1978
Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to miceM A Pacciarini, B Barbieri, T Colombo, et al.The Journal of Pharmacy and Pharmacology|March 1, 1992
Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanismsS Caccia, A Bizzi, G Coltro, et al.Clinical Pharmacology and Therapeutics|March 1, 1986
Reduction of beta-adrenergic receptors by tertatolol: an additional mechanism for beta-adrenergic blockadeA De Blasi, M Lipartiti, F Pirone, et al.Pageof 50